Cargando…
Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants
Developing a vaccine against Chlamydia is key to combating widespread mortalities and morbidities associated with this infection in koalas (Phascolarctos cinereus). In previous studies, we have shown that two or three doses of a Recombinant Major Outer Membrane Protein (rMOMP) antigen-based vaccine,...
Autores principales: | Khan, Shahneaz Ali, Desclozeaux, Marion, Waugh, Courtney, Hanger, Jon, Loader, Jo, Gerdts, Volker, Potter, Andrew, Polkinghorne, Adam, Beagley, Kenneth, Timms, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878773/ https://www.ncbi.nlm.nih.gov/pubmed/27219467 http://dx.doi.org/10.1371/journal.pone.0156094 |
Ejemplares similares
-
A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus)
por: Waugh, Courtney, et al.
Publicado: (2016) -
Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population
por: Nyari, Sharon, et al.
Publicado: (2017) -
Optimising the short and long-term clinical outcomes for koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease
por: Robbins, Amy, et al.
Publicado: (2018) -
Infection with koala retrovirus subgroup B (KoRV-B), but not KoRV-A, is associated with chlamydial disease in free-ranging koalas (Phascolarctos cinereus)
por: Waugh, Courtney A., et al.
Publicado: (2017) -
Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein
por: Nyari, Sharon, et al.
Publicado: (2018)